New treatment for REM sleep behaviour disorder

Time : 31st of May 2023 01:00:19 PM

This disorder is caused due to neurodegeneration from the accumulation of tau protein in the brain. A recent study found that dual orexin receptor antagonists can benefit patients with this condition. These drugs reduced the time to fall asleep and improved the duration and quality of sleep in mouse models, raising hopes for testing these FDA-approved drugs in humans.


REM sleep, behaviour disorder, dual orexin receptor antagonists

Recent Posts

An AI-assisted colonoscopy gets FDA approval
3rd of August 2023 02:43:05 PM

Severe sleep apnea tied to brain abnormalities
1st of August 2023 12:22:47 PM

FDA approves another OTC naloxone nasal spray
1st of August 2023 11:46:02 AM